RAFABLAST Trademark

Trademark Overview

On Friday, October 22, 2010, a trademark application was filed for RAFABLAST with the United States Patent and Trademark Office. The USPTO has given the RAFABLAST trademark a serial number of 85158795. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2014. This trademark is owned by Glaxo Group Limited. The RAFABLAST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
rafablast

General Information

Serial Number85158795
Word MarkRAFABLAST
Filing DateFriday, October 22, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "RAFABLAST" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 27, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB60NN

Trademark Events

Event DateEvent Description
Monday, January 13, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 13, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 6, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 6, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2013EXTENSION 4 GRANTED
Thursday, May 2, 2013EXTENSION 4 FILED
Thursday, May 2, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 5, 2012EXTENSION 3 GRANTED
Thursday, November 1, 2012EXTENSION 3 FILED
Thursday, November 1, 2012TEAS EXTENSION RECEIVED
Friday, May 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 3, 2012EXTENSION 2 GRANTED
Wednesday, April 4, 2012EXTENSION 2 FILED
Wednesday, May 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Thursday, November 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 15, 2011EXTENSION 1 GRANTED
Tuesday, November 15, 2011EXTENSION 1 FILED
Tuesday, November 15, 2011TEAS EXTENSION RECEIVED
Tuesday, June 7, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 12, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2011PUBLISHED FOR OPPOSITION
Saturday, March 5, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 1, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 28, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 28, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 18, 2011ASSIGNED TO LIE
Friday, February 11, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 10, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 10, 2011NON-FINAL ACTION E-MAILED
Monday, January 10, 2011NON-FINAL ACTION WRITTEN
Thursday, January 6, 2011ASSIGNED TO EXAMINER
Wednesday, October 27, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 26, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

rafablast pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological